Related references
Note: Only part of the references are listed.Emerging roles for multipotent, bone marrow-derived stromal cells in host defense
Jeffery J. Auletta et al.
BLOOD (2012)
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
Peter Connick et al.
LANCET NEUROLOGY (2012)
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial
A. J. Coles et al.
NEUROLOGY (2012)
Mesenchymal Stem Cells: Mechanisms of Inflammation
Nora G. Singer et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Mesenchymal stem cells and autoimmune diseases
Francesco Dazzi et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2011)
Evaluating the role of Toll-like receptors in diseases of the central nervous system
Michael Carty et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Autocrine Transforming Growth Factor-β1 Promotes In Vivo Th17 Cell Differentiation
Ilona Gutcher et al.
IMMUNITY (2011)
Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
Taro Kawai et al.
IMMUNITY (2011)
Targeting Toll-like receptors: Emerging therapeutics for multiple sclerosis management
M. Gambuzza et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Mesenchymal stromal cell 'licensing': a multistep process
M. Krampera
LEUKEMIA (2011)
Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α
Yi Liu et al.
NATURE MEDICINE (2011)
The Expression of VEGF-A Is Down Regulated in Peripheral Blood Mononuclear Cells of Patients with Secondary Progressive Multiple Sclerosis
Ellen Iacobaeus et al.
PLOS ONE (2011)
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells
Sabrina Chiesa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease
Jarod Zepp et al.
TRENDS IN IMMUNOLOGY (2011)
Reciprocal Th1 and Th17 Regulation by Mesenchymal Stem Cells: Implication for Multiple Sclerosis
Peter J. Darlington et al.
ANNALS OF NEUROLOGY (2010)
Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study
Jun Liang et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Safety and Immunological Effects of Mesenchymal Stem Cell Transplantation in Patients With Multiple Sclerosis and Amyotrophic Lateral Sclerosis
Dimitrios Karussis et al.
ARCHIVES OF NEUROLOGY (2010)
Interferon-γ-Dependent Inhibition of B Cell Activation by Bone Marrow-Derived Mesenchymal Stem Cells in a Murine Model of Systemic Lupus Erythematosus
Francesca Schena et al.
ARTHRITIS AND RHEUMATISM (2010)
Regenerative Stromal Cell Therapy in Allogeneic Hematopoietic Stem Cell Transplantation: Current Impact and Future Directions
Jeffery J. Auletta et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Emerging therapeutic approaches for multipotent mesenchymal stromal cells
Paolo F. Caimi et al.
CURRENT OPINION IN HEMATOLOGY (2010)
Cytokine networks in multiple sclerosis: lost in translation
Laura Codarri et al.
CURRENT OPINION IN NEUROLOGY (2010)
Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway
Xiaoli Guo et al.
EMBO MOLECULAR MEDICINE (2010)
Protective effects of microglia in multiple sclerosis
Isabella Napoli et al.
EXPERIMENTAL NEUROLOGY (2010)
Immunological Aspects of Allogeneic Mesenchymal Stem Cell Therapies
Matthew D. Griffin et al.
HUMAN GENE THERAPY (2010)
Toll-like Receptor 2 Signaling in CD4+ T Lymphocytes Promotes T Helper 17 Responses and Regulates the Pathogenesis of Autoimmune Disease
Joseph M. Reynolds et al.
IMMUNITY (2010)
Mesenchymal Stem Cells Inhibit Human Th17 Cell Differentiation and Function and Induce a T Regulatory Cell Phenotype
Soufiane Ghannam et al.
JOURNAL OF IMMUNOLOGY (2010)
Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study
Bassem Yamout et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group
Mark S. Freedman et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis
Elizabeth Mallam et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche
Simon Mendez-Ferrer et al.
NATURE (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Modulation of Adult Mesenchymal Stem Cells Activity by Toll-Like Receptors: Implications on Therapeutic Potential
Olga DelaRosa et al.
MEDIATORS OF INFLAMMATION (2010)
Mouse Bone Marrow-Derived Mesenchymal Stromal Cells Turn Activated Macrophages into a Regulatory-Like Profile
Julian Maggini et al.
PLOS ONE (2010)
A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype
Ruth S. Waterman et al.
PLOS ONE (2010)
Animal models of multiple sclerosis-Potentials and limitations
Eilhard Mix et al.
PROGRESS IN NEUROBIOLOGY (2010)
A Consensus Statement Addressing Mesenchymal Stem Cell Transplantation for Multiple Sclerosis: It's Time!
Christopher Siatskas et al.
STEM CELL REVIEWS AND REPORTS (2010)
Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis
Evelien Schurgers et al.
ARTHRITIS RESEARCH & THERAPY (2010)
New concepts on the immune modulation mediated by mesenchymal stem cells
Bruce A. Bunnell et al.
STEM CELL RESEARCH & THERAPY (2010)
Toll-like Receptors in Multiple Sclerosis Mouse Experimental Models
Monica Marta
CONTEMPORARY CHALLENGES IN AUTOIMMUNITY (2009)
Biological characterization of long-term cultured human mesenchymal stem cells
Jiseon Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2009)
Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease
Partow Kebriaei et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Long-term Cultures of Bone Marrow-Derived Human Mesenchymal Stem Cells Frequently Undergo Spontaneous Malignant Transformation (This article contains errors due to a cross contamination of the cell lines we used. To correct this issue we published a letter in Cancer Res. 2010 Aug 1,70(15),6393-6)
Gro Vatne Rosland et al.
CANCER RESEARCH (2009)
Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+ regulatory T cells
K. English et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
EAE: An immunologist's magic eye
Gurumoorthy Krishnamoorthy et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Mesenchymal stem cell-educated macrophages: A novel type of alternatively activated macrophages
Jaehyup Kim et al.
EXPERIMENTAL HEMATOLOGY (2009)
Human Bone Marrow-Derived Mesenchymal Stem Cells Induce Th2-Polarized Immune Response and Promote Endogenous Repair in Animal Models of Multiple Sclerosis
Lianhua Bai et al.
GLIA (2009)
Trafficking and Differentiation of Mesenchymal Stem Cells
Zhao-Jun Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Encephalitogenicity of Complete Freund's Adjuvant Relative to CpG Is Linked to Induction of Th17 Cells
Justine T. Tigno-Aranjuez et al.
JOURNAL OF IMMUNOLOGY (2009)
Mesenchymal Stem Cells Derived from Human Gingiva Are Capable of Immunomodulatory Functions and Ameliorate Inflammation-Related Tissue Destruction in Experimental Colitis
Qunzhou Zhang et al.
JOURNAL OF IMMUNOLOGY (2009)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction
Joshua M. Hare et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis
Neil H. Riordan et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis
J. Liang et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Bone marrow stromal cells attenuate sepsis via prostaglandin E-2-dependent reprogramming of host macrophages to increase their interleukin-10 production
Krisztian Nemeth et al.
NATURE MEDICINE (2009)
Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult rats
E. Keimpema et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2009)
Bone marrow-derived mesenchymal stem cells reduce brain amyloid-β deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model
Jong Kil Lee et al.
NEUROSCIENCE LETTERS (2009)
The effect of delivery via narrow-bore needles on mesenchymal cells
Kapil Agashi et al.
REGENERATIVE MEDICINE (2009)
Toll-Like Receptor Engagement Enhances the Immunosuppressive Properties of Human Bone Marrow-Derived Mesenchymal Stem Cells by Inducing Indoleamine-2,3-dioxygenase-1 via Interferon-beta and Protein Kinase R
Christiane A. Opitz et al.
STEM CELLS (2009)
Toll-like Receptor-Mediated Signaling in Human Adipose-Derived Stem Cells: Implications for Immunogenicity and Immunosuppressive Potential
Eleuterio Lombardo et al.
TISSUE ENGINEERING PART A (2009)
Human Neonatal Thymus-Derived Mesenchymal Stromal Cells: Characterization, Differentiation, and Immunomodulatory Properties
Matthias Siepe et al.
TISSUE ENGINEERING PART A (2009)
Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis
M-C Kastrinaki et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses
Helen Karlsson et al.
BLOOD (2008)
The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe
S. Kidd et al.
CYTOTHERAPY (2008)
Heterogeneity of mesenchymal stromal cell preparations
A. D. Ho et al.
CYTOTHERAPY (2008)
IFN-γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease
David Polchert et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis
Monica Marta et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis
Asa Andersson et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: Implication for assessment of disease activity and treatment
Benedetta Mazzanti et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Autologous mesenchymal bone marrow stem cells: Practical considerations
Neil Scolding et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosis
I. Mueller et al.
LEUKEMIA (2008)
The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study
H. Ning et al.
LEUKEMIA (2008)
Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone
Robert Sackstein et al.
NATURE MEDICINE (2008)
Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing
Liwen Chen et al.
PLOS ONE (2008)
Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing notch signaling
Francesco Liotta et al.
STEM CELLS (2008)
Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses
Suzanne L. Tomchuck et al.
STEM CELLS (2008)
Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis
J. Larghero et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Therapeutic applications of mesenchymal stromal cells
Gary Brooke et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2007)
Hnmunomodulatory properties of mesenchymal stromal cells
Alma J. Nauta et al.
BLOOD (2007)
Immunomodulation by mesenchymal stem cells and clinical experience
K. Le Blanc et al.
JOURNAL OF INTERNAL MEDICINE (2007)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Antoine E. Karnoub et al.
NATURE (2007)
Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term In vitro culture and do not exhibit telomere maintenance mechanisms
Maria Ester Bernardo et al.
CANCER RESEARCH (2007)
Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes
Ida Rasmusson et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients
Mikael Sundin et al.
HAEMATOLOGICA (2007)
Bone morphogenetic proteins promote gliosis in demyelinating spinal cord lesions
Molly L. Fuller et al.
ANNALS OF NEUROLOGY (2007)
Potential risks of bone marrow cell transplantation into infarcted hearts
Martin Breitbach et al.
BLOOD (2007)
Interferon-γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells
J. M. Ryan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells
K. Le Blanc et al.
LEUKEMIA (2007)
IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells
Karen English et al.
IMMUNOLOGY LETTERS (2007)
Mesenchymal stem cells: a new strategy for immunosuppression?
Antonio Uccelli et al.
TRENDS IN IMMUNOLOGY (2007)
Encephalopathy, stroke, and myocardial infarction with DMSO use in stem cell transplantation
Alice S. Chen-Plotkin et al.
NEUROLOGY (2007)
Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis
Ezio Gerdoni et al.
ANNALS OF NEUROLOGY (2007)
Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro
C. Bocelli-Tyndall et al.
RHEUMATOLOGY (2007)
Sarcoma derived from cultured mesenchymal stem cells
Jakub Tolar et al.
STEM CELLS (2007)
Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis
Yaojiong Wu et al.
STEM CELLS (2007)
Immune regulation by mesenchymal stem cells: two sides to the coin
J. Stagg
TISSUE ANTIGENS (2007)
Recurrent herpes simplex virus encephalitis secondary to carbamazepine induced hypogammaglobulinaemia
Claire M. Rice et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Cellular approaches for stimulating CNS remyelination
Robert H. Miller et al.
REGENERATIVE MEDICINE (2007)
Cutting edge:: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-β
Tarik Touil et al.
JOURNAL OF IMMUNOLOGY (2006)
Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells
Brigitte Ruester et al.
BLOOD (2006)
Role of toll-like receptors on human adipose-derived stromal cells
Hyun Hwa Cho et al.
STEM CELLS (2006)
Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells
Francisco T. Rivera et al.
STEM CELLS (2006)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
Bone marrow endothelial progenitors are defective in systemic sclerosis
Nicoletta Del Papa et al.
ARTHRITIS AND RHEUMATISM (2006)
Mesenchymal stem cells as trophic mediators
Arnold I. Caplan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-γ
Jennifer L. Chan et al.
BLOOD (2006)
Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual
M. Sundin et al.
BONE MARROW TRANSPLANTATION (2006)
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease
Olle Ringden et al.
TRANSPLANTATION (2006)
Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators
M Bsibsi et al.
GLIA (2006)
Medical progress: Multiple sclerosis - The plaque and its pathogenesis
EM Frohman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis
M Prinz et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice
JR Munoz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture
Y Wang et al.
CYTOTHERAPY (2005)
Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis
HA Papadaki et al.
BONE MARROW TRANSPLANTATION (2005)
Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon
C Préhaud et al.
JOURNAL OF VIROLOGY (2005)
TLR signaling tailors innate immune responses in human microglia and astrocytes
CS Jack et al.
JOURNAL OF IMMUNOLOGY (2005)
Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice
J Zhang et al.
EXPERIMENTAL NEUROLOGY (2005)
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
E Zappia et al.
BLOOD (2005)
T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia
A Bacigalupo et al.
EXPERIMENTAL HEMATOLOGY (2005)
Tumor necrosis factor a blockade treatment down-modulates the increased systemic and local expression of toll-like receptor 2 and toll-like receptor 4 in spondylarthropathy
L De Rycke et al.
ARTHRITIS AND RHEUMATISM (2005)
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients
HM Lazarus et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness
S Beyth et al.
BLOOD (2005)
T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression
E Klyushnenkova et al.
JOURNAL OF BIOMEDICAL SCIENCE (2005)
Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm
G Prindull et al.
BLOOD (2004)
PML-RARα is associated with leptin-receptor induction:: the role of mesenchymal stem cell-derived adipocytes in APL cell survival
Y Tabe et al.
BLOOD (2004)
The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy
Y Gilgun-Sherki et al.
JOURNAL OF NEUROLOGY (2004)
Replacement of recipient stromal/mesenchymal cells after bone marrow transplantation using bone fragments and cultured osteoblast-like cells
RA Cahill et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease
SM Kerfoot et al.
JOURNAL OF IMMUNOLOGY (2004)
Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta
K Igura et al.
CYTOTHERAPY (2004)
Gastric cancer originating from bone marrow-derived cells
J Houghton et al.
SCIENCE (2004)
Adult human mesenchymal stem cell as a target for neoplastic transformation
N Serakinci et al.
ONCOGENE (2004)
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation
R Meisel et al.
BLOOD (2004)
Mesenchymal stem cells can be differentiated into endothelial cells in vitro
J Oswald et al.
STEM CELLS (2004)
Stem cell plasticity, beyond alchemy
MS Rutenberg et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2004)
Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals
F Djouad et al.
BLOOD (2003)
Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells
I Rasmusson et al.
TRANSPLANTATION (2003)
Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon β1a
F Barkhof et al.
ANNALS OF NEUROLOGY (2003)
Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide
M Krampera et al.
BLOOD (2003)
Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates
SM Devine et al.
BLOOD (2003)
The human umbilical cord blood: A potential source for osteoblast progenitor cells
C Rosada et al.
CALCIFIED TISSUE INTERNATIONAL (2003)
New diagnostic criteria for multiple sclerosis -: Application in first demyelinating episode
M Tintoré et al.
NEUROLOGY (2003)
Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex
K Le Blanc et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2003)
Broad expression of Toll-like receptors in the human central nervous system
M Bsibsi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Mechanisms of disease: The effect of infections on susceptibility to autoimmune and allergic diseases
JF Bach
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Activation of APCs through CD40 or toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease
HT Ichikawa et al.
JOURNAL OF IMMUNOLOGY (2002)
Why does remyelination fail in multiple sclerosis?
RJM Franklin
NATURE REVIEWS NEUROSCIENCE (2002)
Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)
ON Koç et al.
BONE MARROW TRANSPLANTATION (2002)
Pluripotency of mesenchymal stem cells derived from adult marrow
YH Jiang et al.
NATURE (2002)
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone
EM Horwitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Up-regulation of TLR9 gene expression by LPS in mouse macrophages via activation of NF-κB, ERK and p38 MAPK signal pathways
HZ An et al.
IMMUNOLOGY LETTERS (2002)
Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis
JM Murphy et al.
ARTHRITIS AND RHEUMATISM (2002)
Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta
EM Horwitz et al.
BLOOD (2001)
Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy
ON Koc et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)